NASDAQ:BIOL BIOLASE (BIOL) Stock Price, News & Analysis $0.01 0.00 (0.00%) (As of 10/17/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends About BIOLASE Stock (NASDAQ:BIOL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BIOLASE alerts:Sign Up Key Stats Today's Range$0.01▼$0.012050-Day Range$0.01▼$0.0752-Week Range$0.02▼$1.94Volume189,243 shsAverage Volume2.58 million shsMarket Capitalization$384,180.50P/E RatioN/ADividend YieldN/APrice Target$1.20Consensus RatingModerate Buy Company OverviewBIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.Read More… Unlock the Secret to Earning Consistent Income from Stocks Under $30! (Ad)Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE!👉 Yes, I Want the Free Report! 👈 BIOLASE Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks27th Percentile Overall ScoreBIOL MarketRank™: BIOLASE scored higher than 27% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingBIOLASE has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageBIOLASE has only been the subject of 2 research reports in the past 90 days.Read more about BIOLASE's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of BIOLASE is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of BIOLASE is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for BIOL. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBIOLASE does not currently pay a dividend.Dividend GrowthBIOLASE does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for BIOL. News and Social Media2.4 / 5News Sentiment0.31 News SentimentBIOLASE has a news sentiment score of 0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.70 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for BIOLASE this week, compared to 1 article on an average week.Search InterestOnly 3 people have searched for BIOL on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows3 people have added BIOLASE to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, BIOLASE insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.27% of the stock of BIOLASE is held by insiders.Percentage Held by InstitutionsOnly 8.79% of the stock of BIOLASE is held by institutions.Read more about BIOLASE's insider trading history. Receive BIOL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BIOLASE and its competitors with MarketBeat's FREE daily newsletter. Email Address BIOL Stock News HeadlinesStockNews.com Initiates Coverage on BIOLASE (NASDAQ:BIOL)October 13, 2024 | americanbankingnews.comIncreasing Prevalence of Periodontal Diseases to Propel Dental Market Growth at a CAGR of 7.4% by 2031October 12, 2024 | theglobeandmail.comThese LIVE trade signals would have dished out how much money? 51 LIVE trade signals…and you won’t believe how much some of my members could have grown their account! Seriously, for the first “beta testers” of this weekly income strategy…. The returns were JAW-DROPPING. How much could they have grown their $10k starting account?October 18, 2024 | DTI (Ad)Sonendo Executes Asset Purchase Agreement to Acquire Biolase AssetsOctober 9, 2024 | finance.yahoo.com**BIOLASE Announces Submission of Form 8-K Filing Concerning XYZ Deal** October 8, 2024 | americanbankingnews.comBiolase stock in flux as company files for bankruptcyOctober 4, 2024 | investing.comDental Equipment Market Size Worth USD 10.90 Billion By 2031 | CAGR 6.10% : Skyquest TechnologySeptember 27, 2024 | theglobeandmail.comCosmetic Dentistry Market to Grow by USD 22.97 Billion (2024-2028) Driven by Increased Oral Care Awareness and AI Trends - Technavio ReportSeptember 11, 2024 | finance.yahoo.comSee More Headlines BIOL Stock Analysis - Frequently Asked Questions How have BIOL shares performed this year? BIOLASE's stock was trading at $1.1220 at the beginning of 2024. Since then, BIOL shares have decreased by 99.0% and is now trading at $0.0115. View the best growth stocks for 2024 here. How were BIOLASE's earnings last quarter? BIOLASE, Inc. (NASDAQ:BIOL) posted its quarterly earnings results on Thursday, August, 8th. The medical technology company reported ($0.08) EPS for the quarter. The medical technology company had revenue of $11.56 million for the quarter. BIOLASE had a negative trailing twelve-month return on equity of 1,782.73% and a negative net margin of 41.65%. When did BIOLASE's stock split? Shares of BIOLASE reverse split on Friday, July 28th 2023. The 1-100 reverse split was announced on Friday, July 28th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, July 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split. How do I buy shares of BIOLASE? Shares of BIOL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of BIOLASE own? Based on aggregate information from My MarketBeat watchlists, some other companies that BIOLASE investors own include Bionano Genomics (BNGO), Tonix Pharmaceuticals (TNXP), SNDL (SNDL), Zomedica (ZOM), NIO (NIO), Exela Technologies (XELA) and Ocugen (OCGN). Company Calendar Last Earnings8/08/2024Today10/17/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Dental equipment & supplies Sub-IndustryMedical Equipment Current SymbolNASDAQ:BIOL Previous SymbolNASDAQ:BLTI CUSIPN/A CIK811240 Webwww.biolase.com Phone(949) 361-1200Fax949-273-6677Employees160Year FoundedN/APrice Target and Rating Average Stock Price Target$1.20 High Stock Price Target$2.00 Low Stock Price Target$0.40 Potential Upside/Downside+10,334.8%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($14.94) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-20,630,000.00 Net Margins-41.65% Pretax Margin-41.56% Return on Equity-1,782.73% Return on Assets-55.31% Debt Debt-to-Equity RatioN/A Current Ratio0.71 Quick Ratio0.36 Sales & Book Value Annual Sales$48.83 million Price / Sales0.01 Cash FlowN/A Price / Cash FlowN/A Book Value($0.07) per share Price / Book-0.16Miscellaneous Outstanding Shares33,407,000Free Float33,317,000Market Cap$384,180.50 OptionableNot Optionable Beta0.67 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report This page (NASDAQ:BIOL) was last updated on 10/18/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredAdd $2T of Potential Magic to Your PortfolioRevolutionizing a whole $2T entertainment and licensing industry might sound like the stuff of fairytales. But...Elf Labs | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredMassive trading opportunity begins by October 21 October 21 could spark a mania among “next-generation” AI stocks. That’s the newest prediction from a Wall Str...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BIOLASE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BIOLASE With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.